In vitro non-homologous DNA end joining assays-The 20th anniversary

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 6, 2009, Pages 1254-1260

  Pastwa, Elzbieta ^a   Somiari, Richard I ^b   Malinowski, Mariusz ^a   Somiari, Stella B ^c   Winters, Thomas A ^d  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Functional Genomics and Proteomics   (United States)

^c WINDBER RESEARCH INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Anticancer drugs; DNA double strand breaks; DNA repair; In vitro assays; Non homologous DNA end joining

Indexed keywords

CANCER DIAGNOSIS; CANCER THERAPY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; HUMAN; MOLECULAR MECHANICS; NON HOMOLOGOUS DNA END JOINING; NONHUMAN; REVIEW;

ANIMALS; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA REPAIR ENZYMES; HUMANS;

MAMMALIA;

EID: 60649092887     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.11.007     Document Type: Review

References (64)

1. Ahnesorg P., Smith P., and Jackson S.P. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124 (2006) 301-313
2. Albert J.M., Cao C., Kim K.W., Willey C.D., Geng L., Xiao D., et al. Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Clin Cancer Res 13 (2007) 3033-3042
3. Bau D.T., Mau Y.C., Ding S.L., Wu P.E., and Shen C.Y. DNA double-strand break repair capacity and risk of breast cancer. Carcinogenesis 8 (2007) 1726-1730
4. Baumann P., and West S.C. DNA end-joining catalyzed by human cell-free extracts. Proc Natl Acad Sci USA 95 (1998) 14066-14070
5. Beyert N., Reichenberger S., Peters M., Hartung M., Göttlich B., Goedecke W., et al. Nonhomologous DNA end joining of synthetic hairpin substrates in Xenopus laevis egg extracts. Nucleic Acids Res 22 (1994) 1643-1650
6. Buck D., Malivert L., de Chasseval R., Barraud A., Fondanèche M.C., Sanal O., et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124 (2006) 287-299
7. Budman J., and Chu G. Processing of DNA for nonhomologous end-joining by cell-free extract. EMBO J 24 (2005) 849-860
8. Budman J., and Chu G. Assays for nonhomologous end joining in extracts. Methods Enzymol 408 (2006) 430-444
9. Budman J., Kim S.A., and Chu G. Processing of DNA for nonhomologous end-joining is controlled by kinase activity and XRCC4/ligase IV. J Biol Chem 282 (2007) 11950-11959
10. Chappell C., Hanakahi L.A., Karimi-Busheri F., Weinfeld M., and West S.C. Involvement of human polynucleotide kinase in double-strand break repair by non-homologous end joining. EMBO J 21 (2002) 2827-2832
11. Cheong N., Perrault A.R., and Iliakis G. In vitro rejoining of DNA double strand breaks: a comparison of genomic-DNA with plasmid-DNA-based assays. Int J Radiat Biol 73 (1998) 481-493
12. Chistiakov D.A., Voronova N.V., and Chistiakov P.A. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Acta Oncol 47 (2008) 809-824
13. Datta K., Neumann R.D., and Winters T.A. An in vitro nonhomologous end-joining assay using linear duplex oligonucleotides. Anal Biochem 358 (2006) 155-157
14. Datta K., Weinfeld M., Neumann R.D., and Winters T.A. Determination and analysis of site-specific 125I decay-induced DNA double-strand break end-group structures. Radiat Res 167 (2007) 152-166
15. Dai Y., Kysela B., Hanakahi L.A., Manolis K., Riballo E., Stumm M., et al. Nonhomologous end joining and V(D)J recombination require an additional factor. Proc Natl Acad Sci USA 100 (2003) 2462-2467
16. DeFazio L.G., Stansel R.M., Griffith J.D., and Chu G. Synapsis of DNA ends by DNA-dependent protein kinase. EMBO J 21 (2002) 3192-3200
17. Diggle C.P., Bentley J., and Kiltie A.E. Development of a rapid, small-scale DNA repair assay for use on clinical samples. Nucleic Acids Res 31 (2003) e83
18. Fairman M.P., Johnson A.P., and Thacker J. Multiple components are involved in the efficient joining of double stranded DNA breaks in human cell extracts. Nucleic Acids Res 20 (1992) 4145-4152
19. Gu X.Y., Bennett R.A., and Povirk L.F. End-joining of free radical-mediated DNA double-strand breaks in vitro is blocked by the kinase inhibitor wortmannin at a step preceding removal of damaged 3′ termini. J Biol Chem 271 (1996) 19660-19663
20. Gu X.Y., Weinfeld M.A., and Povirk L.F. Implication of DNA-dependent protein kinase in an early, essential, local phosphorylation event during end-joining of DNA double-strand breaks in vitro. Biochemistry 37 (1998) 9827-9835
21. Gu Y., Jin S., Gao Y., Weaver D.T., and Alt F.W. Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination. Proc Natl Acad Sci USA 94 (1997) 8076-8081
22. Hanakahi L.A., Bartlet-Jones M., Chappell C., Pappin D., and West S.C. Binding of inositol phosphate to DNA-PK and stimulation of double-strand break repair. Cell 102 (2000) 721-729
23. Hanakahi L.A., and West S.C. Specific interaction of IP6 with human Ku70/80, the DNA-binding subunit of DNA-PK. EMBO J 21 (2002) 2038-2044
24. Hay T., Jenkins H., Sansom O.J., Martin N.M., Smith G.C., and Clarke A.R. Efficient deletion of normal Brca2-deficient intestinal epithelium by poly(ADP-ribose) polymerase inhibition models potential prophylactic therapy. Cancer Res 65 (2005) 10145-10148
25. Iliakis G., and Cheong N. In vitro rejoining of double-strand breaks in genomic DNA. Methods Mol Biol 314 (2006) 95-108
26. Iliakis G., Rosidi B., Wang M., and Wang H. Plasmid-based assays for DNA end-joining in vitro. Methods Mol Biol 314 (2006) 123-131
27. Interthal H., Pouliot J.J., and Champoux J.J. The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc Natl Acad Sci USA 98 (2001) 12009-12014
28. Kim W., Seong J., An J.H., and Oh H.J. Enhancement of tumor radioresponse by wortmannin in C3H/HeJ hepatocarcinoma. J Radiat Res (Tokyo) 48 (2007) 187-195
29. Labhart P. Ku-dependent nonhomologous DNA end joining in Xenopus egg extracts. Mol Cell Biol 19 (1999) 2585-2593
30. Lees-Miller S.P., Godbout R., Chan D.W., Weinfeld M., Day III R.S., Barron G.M., et al. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 267 (1995) 1183-1185
31. Lieber M.R. The mechanism of human nonhomologous DNA end joining. J Biol Chem 283 (2008) 1-5
32. Ma Y., Pannicke U., Schwarz K., and Lieber M.R. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108 (2002) 781-794
33. Ma Y., Lu H., Tippin B., Goodman M.F., Shimazaki N., Koiwai O., et al. A biochemically defined system for mammalian nonhomologous DNA end joining. Mol Cell 16 (2004) 701-713
34. Ma Y., and Lieber M.R. In vitro nonhomologous DNA end joining system. Methods Enzymol 408 (2006) 502-510
35. Malinowski M., and Pastwa E. Double-strand breaks repair by non-homologous DNA end joining in mammalian cells. Curr Genomics 7 (2006) 311-322
36. Nick McElhinny S.A., Snowden C.M., McCarville J., and Ramsden D.A. Ku recruits the XRCC4-ligase IV complex to DNA ends. Mol Cell Biol 20 (2000) 2996-3003
37. Nick McElhinny S.A., Havener J.M., Garcia-Diaz M., Juárez R., Bebenek K., Kee B.L., et al. A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomologous end joining. Mol Cell 19 (2005) 357-366
38. North P., Ganesh A., and Thacker J. The rejoining of double-strand breaks in DNA by human cell extracts. Nucleic Acids Res 18 (1990) 6205-6210
39. O'Connor M.J., Martin N.M., and Smith G.C. Targeted cancer therapies based on the inhibition of DNA strand break repair. Oncogene 26 (2007) 7816-7824
40. Odersky A., Panyutin I.V., Panyutin I.G., Schunck C., Feldmann E., Goedecke W., et al. Repair of sequence-specific 125I-induced double-strand breaks by nonhomologous DNA end joining in mammalian cell-free extracts. J Biol Chem 277 (2002) 11756-11764
41. Panyutin I.G., and Neumann R.D. Sequence-specific DNA double-strand breaks induced by triplex forming 125I labeled oligonucleotides. Nucleic Acids Res 22 (1994) 4979-4982
42. Panyutin I.G., and Neumann R.D. Sequence-specific DNA breaks produced by triplex-directed decay of iodine-125. Acta Oncol 35 (1996) 817-823
43. Pastwa E., Neumann R.D., and Winters T.A. In vitro repair of complex unligatable oxidatively induced DNA double-strand breaks by human cell extracts. Nucleic Acids Res 29 (2001) E78
44. Pastwa E., Neumann R.D., Mezhevaya K., and Winters T.A. Repair of radiation-induced DNA double-strand breaks is dependent upon radiation quality and the structural complexity of double-strand breaks. Radiat Res 159 (2003) 251-261
45. Pastwa E., and Blasiak J. Non-homologous DNA end joining. Acta Biochim Pol 50 (2003) 891-908
46. Pastwa E., Poplawski T., Czechowska A., Malinowski M., and Blasiak J. Non-homologous DNA end joining repair in normal and leukemic cells depends on the substrate ends. Z Naturforsch [C] 60 (2005) 493-500
47. Pastwa E., and Malinowski M. Non-homologous DNA end joining in anticancer therapy. Curr Cancer Drug Targets 7 (2007) 243-250
48. Pavón M.A., Parreño M., León X., Sancho F.J., Céspedes M.V., Casanova I., et al. Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer. Int J Cancer 123 (2008) 1068-1079
49. Pfeiffer P., and Vielmetter W. Joining of nonhomologous DNA double strand breaks in vitro. Nucleic Acids Res 16 (1988) 907-924
50. Plo I., Liao Z.Y., Barceló J.M., Kohlhagen G., Caldecott K.W., Weinfeld M., et al. Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesions. DNA Repair (Amst) 2 (2003) 1087-1100
51. Povirk L.F. Biochemical mechanisms of chromosomal translocations resulting from DNA double-strand breaks. DNA Repair (Amst) 5 (2006) 1199-1212
52. Povirk L.F., Zhou T., Zhou R., Cowan M.J., and Yannone S.M. Processing of 3′-phosphoglycolate-terminated DNA double strand breaks by Artemis nuclease. J Biol Chem 282 (2007) 3547-3558
53. Riballo E., Critchlow S.E., Teo S.H., Doherty A.J., Priestley A., Broughton B., et al. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol 9 (1999) 699-702
54. Sakata K., Someya M., Matsumoto Y., and Hareyama M. Ability to repair DNA double-strand breaks related to cancer susceptibility and radiosensitivity. Radiat Med 25 (2007) 433-438
55. Shrivastav M., De Haro L.P., and Nickoloff J.A. Regulation of DNA double-strand break repair pathway choice. Cell Res 18 (2008) 134-147
56. Takashima H., Boerkoel C.F., John J., Saifi G.M., Salih M.A., Armstrong D., et al. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat Genet 32 (2002) 267-272
57. van Gent D.C., and van der Burg M. Non-homologous end-joining, a sticky affair. Oncogene 26 (2007) 7731-7740
58. Viau M., Gastaldo J., Bencokova Z., Joubert A., and Foray N. Cadmium inhibits non-homologous end-joining and over-activates the MRE11-dependent repair pathway. Mutat Res 654 (2008) 13-21
59. Wang H., Perrault A.R., Takeda Y., Qin W., Wang H., and Iliakis G. Biochemical evidence for Ku-independent backup pathways of NHEJ. Nucleic Acids Res 31 (2003) 5377-5388
60. Weterings E., and Chen D.J. The endless tale of non-homologous end-joining. Cell Res 18 (2008) 114-124
61. Winters T.A., Pastwa E., Datta K., and Neumann R.D. Rational drug development using gene-targeted agents and their application in anti-gene radiotherapy. Curr Genomics 4 (2003) 109-121
62. Winters T.A., Weinfeld M., and Jorgensen T.J. Human HeLa cell enzymes that remove phosphoglycolate 3′-end groups from DNA. Nucleic Acids Res 20 (1992) 2573-2580
63. Yano K., Morotomi-Yano K., Wang S.Y., Uematsu N., Lee K.J., Asaithamby A., et al. Ku recruits XLF to DNA double-strand breaks. EMBO Rep 9 (2008) 91-96
64. Yu H.G., Ai Y.W., Yu L.L., Zhou X.D., Liu J., Li J.H., et al. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer 122 (2008) 433-443